Goldstone, S.E. and Vucocolo, S. (2012) A Prophylactic Quadrivalent Vaccine for the Prevention of Infection and Disease Related to HPV-6, -11, -16 and -18. Expert Review of Vaccines, 11, 395-406. http://dx.doi.org/10.1586/erv.12.20
 Saslow, D., Solomon, D., Lawson, H.W., et al. (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for Prevention and Early Detection of Cervical Cancer. CA: A Cancer Journal for Clinicians.
 Moyer, V.A. on Behalf of the US Preventive Services Task Force (2012) Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 156, 880-892. http://dx.doi.org/10.7326/0003-4819-156-12-201206190-00424
 Rodriguez, M.A., Ward, L.M. and Perez-Stable, E.J. (2005) Breast and Cervical Cancer Screening: Impact of Health Insurance Status, Ethnicity and Nativity of Latinas. Annals of Family Medicine, 3, 235-241. http://dx.doi.org/10.1370/afm.291
 Fedewa, S.A., Cokkinides, V., Virgo, K.S., et al. (2011) Association of Insurance Status and Age with Cervical Cancer Stage At Diagnosis: National Cancer Database, 2000-2007. American Journal of Public Health, 102, 1782-1790. http://dx.doi.org/10.2105/AJPH.2011.300532
 Sloan-Barnholtz, J., Patel, N., Rollison, D., et al. (2009) Incidence Trends of Invasive Cervical Cancer in the United States by Combined Race and Ethnicity. Cancer Causes and Control, 20, 1129-1138. http://dx.doi.org/10.1007/s10552-009-9317-z
 Schwartz, J.L., Caplan, A.L., Faden, R.R., et al. (2007) Lessons from the Failure of Human Papillomavirus Vaccine State Requirements. Clinical Pharmacology and Therapeutics, 82, 760-763.
 Kim, J.J. and Goldie, S.J. (2008) Health and Economic Implications of HPV Vaccination in the United States. The New England Journal of Medicine, 359, 821-832.
 Goldie, S.J., Kuhn, L., Denny, L., et al. (2001) Policy Analysis of Cervical Cancer Screening in Low-Resource Settings: Clinical Benefits and Cost Effectiveness. JAMA, 285, 3107-3115.
 Adams, E., Breen, N. and Joski, P. (2006) Impact of the National Breast and Cervical Cancer Early Detection Program on Mammography and Pap Test Utilization Among White, Hispanic, and African American Women: 1996-2000. Cancer, 109, 348-358.
 Baker, L. and Chan, J. (2007) Laws Requiring Health Plans to Provide Direct Access to Obstetricians and Gynecologists, and Use of Cancer Screening by Women. Health Services Research, 42, 990-1006. http://dx.doi.org/10.1111/j.1475-6773.2006.00646.x
 Boss, L. and Guckes, F. (1992) Medicaid Coverage of Screening Tests for Breast and Cervical Cancer. American Journal of Public Health, 82, 252-253. http://dx.doi.org/10.2105/AJPH.82.2.252
 Moore, K. (1992) A Survey of State Medicaid Policies for Coverage of Screening Mammography and Pap Smear Services. Women’s Health Issues, 2, 40-49. http://dx.doi.org/10.1016/S1049-3867(05)80136-7
 Lantz, P.M., Weigers, M.E. and House, J.S. (1997) Education and Income Differentials in Breast and Cervical Cancer Screening: Policy Implications for Rural Women. Medical Care, 35, 219-236.
 Mariotto, A.B., Yabroff, K.R., Shao, Y., et al. (2011) Projections of the Cost of Cancer Care in the United States: 2010-2020. Journal of the National Cancer Institute, 103, 117-128.
 Rochester, P.W., Townsend, J.S., Given, L., et al. (2010) Comprehensive Cancer Control: Progress and Accomplishments. Ca Causes and Control, 21, 1967-1977. http://dx.doi.org/10.1007/s10552-010-9657-8
 Hager, P., Given, L., Redmond, J. and Rogers, K. (2010) Revision of Comprehensive Cancer Control Plans: Experiences Shared by Three States. Ca Causes and Control, 21, 2005-2013.